Worldwide—Global Evaluation Framework Agreement 1 and 2

Client: Foreign, Commonwealth & Development Office

Duration: 2012-2018

Region: Worldwide

Country: Worldwide

Solutions: Global Health

DAI Global Health was a prime contractor for the Global Evaluation Framework Agreement 2 (GEFA 2) for Lot 1, covering Impact Evaluation. GEFA 2 ensured the provision of efficient and effective expert services for the design and implementation of evaluations delivered by the former U.K. Department for International Development (now called Foreign, Commonwealth & Development Office) and other government departments. With Triple Line, DAI Global Health conducted the project evaluation of the FCDO-funded Health Partnership Scheme Programme, culminating in a presentation of the final report at the October 2016 Tropical Health and Education Trust (THET) Conference.

All consortium partners provided technical assistance to support human development in the following areas: health, water supply, sanitation, social protection, and education.

This framework built upon its predecessor GEFA 1, through which Health Partners International supported the implementation of the Evaluation of Maternal Newborn and Child Health Programme in Zimbabwe and the Evaluation of the Health Partnership Scheme.

GEFA 2 covered a range of geographic locations including fragile and conflicted-affected states.

Select Results

Under the framework’s first phase, we:

  • Provided niche technical expertise in health and social development as a prime contractor on the Global Evaluation Framework Agreement.
  • Provided technical support in the following thematic areas: health, governance, capacity building, social development, and aid instruments.
  • Conducted an overall evaluation of Maternal Newborn and Child Health Programme in Zimbabwe.
x

RELATED CONTENT:

Kenya—Integrated Pharmaceutical and Supply Chain Technical Assistance (KIPS)

The Integrated Pharmaceutical and Supply Chain Technical Assistance Activity works to ensure more sustainable access to—and appropriate use of—quality-assured and affordable health commodities in Kenya by supporting the development of an increasingly resilient and mature supply chain system and pharmaceutical regulatory services.

Read More